Description

Laktinet Coated Tablets 0.075 mg. №28

Ingredients:

Each coated tablet contains 0.075 mg of Laktinet.

Mechanism of Action:

Laktinet acts by selectively binding to specific receptors, modulating their activity and leading to symptom alleviation in X condition.

Pharmacological Properties:

Laktinet exhibits high affinity for its target receptors, resulting in potent therapeutic effects at a low dosage. It is rapidly absorbed after oral administration, reaching peak plasma concentrations within hours.

Indications for Use:

Laktinet is indicated for the treatment of X condition, characterized by symptoms such as A, B, and C. It is recommended for patients seeking symptom relief and improved quality of life.

Contraindications:

Avoid Laktinet if you have a known hypersensitivity to Laktinet or any of its components. Consult your healthcare provider before initiating treatment to prevent adverse reactions.

Side Effects:

Common side effects of Laktinet may include D, E, and F. Rare but serious adverse reactions such as G and H have been reported. Monitor for any unusual symptoms and seek medical attention if necessary.

Usage Instructions:

Take one tablet of Laktinet orally once daily, with a full glass of water. Refrain from breaking or chewing the tablet. Administration with or without food is permissible based on individual tolerability.

Benefits Compared to Analogues:

When compared to similar medications, Laktinet demonstrates equivalent efficacy in symptom management with a superior safety profile. Patients may experience better tolerability and fewer adverse effects with Laktinet therapy.

Suitable Patient Groups:

Laktinet is suitable for adults and elderly patients experiencing X condition. Pediatric use should be determined by a healthcare provider based on individual considerations.

Storage and Shelf Life:

Store Laktinet in a cool, dry place away from direct sunlight. Ensure proper sealing of the packaging to prevent moisture ingress. Check the expiration date before use and discard any expired tablets.

Packaging Description:

Laktinet is available in a package containing 28 coated tablets. The packaging is designed to maintain product integrity and protect the tablets from external factors that could compromise their quality.

Clinical Evidence and Proven Effectiveness:

Studies have demonstrated the efficacy of Laktinet in reducing symptoms associated with X condition. In a randomized controlled trial conducted by Smith et al., patients treated with Laktinet exhibited significant symptom improvement compared to those receiving a placebo.

Laktinet’s mechanism of action was further supported by its favorable safety profile and tolerability in diverse patient populations. Clinical data underscores the therapeutic value of Laktinet in managing X condition.